image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Secondary Recommendation

Synergy Health

November 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 743p
Synergy has announced that earnings for the six months to 26 September are expected to be in line with expectations. The margin growth seen in Q1 has continued into Q2, while there has been further revenue growth in the sterilisation and decontamination divisions, although this has slightly been offset by zero growth in revenues from the linen side and by the wind-down of its non-core businesses. The bid pipeline is improving and new contract wins worth £60m have been added to the order book, taking the total to c. £860m. The shares have had a strong run in the past six months and are close to several brokers’ price targets. Given that the gain since we added them to the Trader Portfolio at 2 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Synergy Health - Offer triggers gains of 875% (December 2014)
Synergy Health - US and Asia growing at 16-18% (January 2013)
Synergy Health - Acquisition opens doorgrade to huge US market (August 2012)
Synergy Health - Brewin lifts price target (August 2011)
Synergy Health (June 2011)
Synergy Health - Gain to date: 289% (March 2011)
Synergy Health - Eps up 23% (July 2010)
Synergy Health - Eps at top end of expectations (June 2010)
Synergy Health - Excellent growth in sales and margins (March 2010)
Synergy Health - Order book remains strong (January 2010)
Synergy Heath (September 2009)
Synergy Health - Margins recovering (July 2009)
Synergy Healthcare - Shares surge on positive update (May 2009)
Synergy Healthcare (March 2009)
Synergy Healthcare - Hike in costs triggers warning (December 2008)
Synergy Healthcare - Q1 sales up 30% (September 2008)
Synergy Healthcare (July 2008)
Synergy Healthcare - (January 2008)
Synergy Healthcare - Interims due 20 November (December 2007)
Synergy Healthcare - 286% gain to date (August 2007)
Synergy Healthcare - Expansion into China (July 2007)
Synergy Healthcare - Increases bid for Isotron (January 2007)
Synergy Healthcare (December 2006)
Synergy Healthcare (November 2006)
Synergy Healthcare (September 2006)
Synergy Healthcare (July 2006)
Synergy Healthcare (January 2006)
Synergy Healthcare - Acquisition of Shilo provides new NHS opportunity (August 2005)
Synergy Healthcare - 90% of this year's sales now booked (July 2005)
Synergy Healthcare - Surgical support servives provider exploiting huge NHS demand (December 2004)
Synergy Healthcare - Shares inch to all-time high (November 2004)
Synergy Healthcare - Acquisition triggers massive earnings upgrade (July 2004)
Synergy Healthcare - In the running for more PFI contracts (May 2004)
Synergy Healthcare (March 2004)
Synergy Healthcare - Preferred bidder for second PFI (December 2003)
Synergy Healthcare - Huge NHS opportunity (July 2003)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X